This pages lists the MSc. Theses topics currently available in our group. Don't hesitate to contact the respective person if you are interested in one of the topics. If you would like to write a thesis about your own idea you can propose it to the person most related to what you plan to do or you can contact Prof. Bernstein directly.
Crowdsourcing has raised interest in both the scientific and industrial community as a collaboration model enabling the general public to join forces in order to solve otherwise challenging problems by posting them in an open call manner. Whereas the effectiveness of crowdsourcing in solving tedious, aggregative tasks is widely acknowledged, the understanding of how to crowdsource highly complex and ill-defined tasks such as data analysis is not yet fully discerned.
This thesis will investigate massively collaborative data analysis scenarios that involve diverse people with varying (and possibly limited) relevant knowledge. The goal of this thesis is to develop and evaluate a novel approach to supporting collaborative data analysis, and contribute to a better understanding of data analysis as a collaborative and distributed process accessible to a wide range of people with a diverse set of skills.
Your work will involve analytical aspect of designing processes that will allow non-experts to collaborate with data scientists to solve most exciting questions by taking advantage of the available data. Part of your thesis will be to build a prototype to evaluate your ideas in the real world setting by recruiting freelancers and data scientists. If you are interested in extending your knowledge in the domain of data analysis and excited about the opportunities of democratizing the data - driven research you should consider applying for this thesis.
Contact: Michael Feldman
Alzheimer’s is a fatal disease of the brain, the sixth-leading cause of death in the United States and the only cause of death among the top 10 that cannot be prevented, cured or even slowed . While Alzheimer has attracted significant investments from major pharmaceutical firms, it has also been a meager disease area for innovation, with most promising new drug candidates failing phase III of clinical trials .
Given the state of pharmaceutical treatment as urgency of the disease, doctors and caregivers have started exploring and adopting alternative non-pharmaceutical treatments to deal with the symptoms of the disease. Patients and their caregivers extensively exchange knowledge about such treatments in online forums (e.g. www.alzconnected.org, http://forum.alzheimers.org.uk/).
Contact: Abraham Bernstein